Lv3
332 积分 2023-06-25 加入
FGF13基因c.-32C>G半合子变异5个家系的致病性分析及产前咨询
3天前
已完结
The complex karyotype in hematological malignancies: a comprehensive overview by the Francophone Group of Hematological Cytogenetics (GFCH)
1个月前
已完结
Implementation of Standardized International Karyotype Scoring Practices Is Needed to Provide Uniform and Systematic Evaluation for Patients with Myelodysplastic Syndrome Using IPSS Criteria: An International Working Group on MDS Cytogenetics Study
1个月前
已完结
Validation of a rapid fluorescence immunoassay for soluble interleukin-2 receptor α in a pediatric population
1个月前
已完结
MYD88 Mutations: Transforming the Landscape of IgM Monoclonal Gammopathies
1个月前
已完结
Randomized phase II trial of gemcitabine–cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancer
1个月前
已完结
Trastuzumab Deruxtecan in Patients With HER2-Overexpressing NSCLC: Results From Part 1 of the Open-Label, Multicenter, Phase 1b DESTINY-Lung03 Trial
2个月前
已完结
Trastuzumab Deruxtecan in Patients With HER2-Overexpressing NSCLC: Results From Part 1 of the Open-Label, Multicenter, Phase 1b DESTINY-Lung03 Trial
2个月前
已完结
Trastuzumab Deruxtecan in Patients From China With Pretreated HER2-Mutant Non-Small Cell Lung Cancer: Final Analysis of the Phase 2, Single-Arm DESTINY-Lung05 Trial
2个月前
已完结
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial
2个月前
已完结
皖公网安备34019202002308
